Author:
Schifano Fabrizio,Napoletano Flavia,Chiappini Stefania,Orsolini Laura,Guirguis Amira,Corkery John Martin,Bonaccorso Stefania,Ricciardi Angelo,Scherbaum Norbert,Vento Alessandro
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Clinical Psychology
Reference154 articles.
1. EMCDDA. EMCDDA–Europol 2017 Annual Report on the implementation of Council Decision 2005/387/JHA. EMCDDA: Lisbon, 2018. Available from: http://www.emcdda.europa.eu/system/files/publications/9282/20183924_TDAN18001ENN_PDF.pdf Accessed 09th December 2018.
2. Schifano F. Recent changes in drug abuse scenarios: the new/novel psychoactive substances (NPS) phenomenon. Brain Sci. 2018;8(12).
3. Jaffe JH. Drug addiction and drug abuse. In: Goodman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 8th ed. New York: McGraw Hill; 1990. p. 522–73.
4. • Martinotti G, Santacroce R, Pettorruso M, Montemitro C, Spano MC, Lorusso M, et al. Hallucinogen persisting perception disorder: etiology, clinical features, and therapeutic perspectives. Brain Sci. 2018;8(3). This review focused on the aetiology of Hallucinogen Persisting Perception Disorder induction, the possible hallucinogens involved, the clinical features, the possible psychiatric comorbidities, and the available potential therapeutic strategies.
5. Schifano F, Orsolini L, Duccio Papanti G, Corkery JM. Novel psychoactive substances of interest for psychiatry. World Psychiatry. 2015;14(1):15–26.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献